Annual Retained Earnings
-$1.28 B
-$255.10 M-24.78%
31 December 2023
Summary:
10x Genomics annual retained earnings is currently -$1.28 billion, with the most recent change of -$255.10 million (-24.78%) on 31 December 2023. During the last 3 years, it has fallen by -$421.10 million (-48.78%). TXG annual retained earnings is now -982.70% below its all-time high of -$118.63 million, reached on 31 December 2017.TXG Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.42 B
-$35.75 M-2.59%
30 September 2024
Summary:
10x Genomics quarterly retained earnings is currently -$1.42 billion, with the most recent change of -$35.75 million (-2.59%) on 30 September 2024. Over the past year, it has dropped by -$133.60 million (-10.40%). TXG quarterly retained earnings is now -473.45% below its all-time high of $379.71 million, reached on 01 September 2017.TXG Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -10.4% |
| 3 y3 years | -48.8% | -64.3% |
| 5 y5 years | -389.6% | -440.5% |
TXG Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -48.8% | at low | -64.3% | at low |
| 5 y | 5 years | -389.6% | at low | -440.5% | at low |
| alltime | all time | -982.7% | at low | -473.4% | at low |
10x Genomics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.42 B(+2.6%) |
| June 2024 | - | -$1.38 B(+2.8%) |
| Mar 2024 | - | -$1.34 B(+4.7%) |
| Dec 2023 | -$1.28 B(+24.8%) | -$1.28 B(+4.0%) |
| Sept 2023 | - | -$1.24 B(+8.1%) |
| June 2023 | - | -$1.14 B(+5.8%) |
| Mar 2023 | - | -$1.08 B(+4.9%) |
| Dec 2022 | -$1.03 B(+19.2%) | -$1.03 B(+1.7%) |
| Sept 2022 | - | -$1.01 B(+4.3%) |
| June 2022 | - | -$970.19 M(+7.1%) |
| Mar 2022 | - | -$905.73 M(+4.9%) |
| Dec 2021 | -$863.32 M(+7.2%) | -$863.32 M(+2.2%) |
| Sept 2021 | - | -$844.87 M(+2.1%) |
| June 2021 | - | -$827.70 M(+1.4%) |
| Mar 2021 | - | -$816.65 M(+1.4%) |
| Dec 2020 | -$805.10 M | -$805.10 M(+106.7%) |
| Sept 2020 | - | -$389.52 M(+20.3%) |
| June 2020 | - | -$323.68 M(+14.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$283.51 M(+8.1%) |
| Dec 2019 | -$262.37 M(+13.5%) | -$262.37 M(+2.8%) |
| Sept 2019 | - | -$255.23 M(+3.9%) |
| June 2019 | - | -$245.63 M(+6.3%) |
| Dec 2018 | -$231.12 M(+94.8%) | -$231.12 M(-160.9%) |
| Dec 2017 | -$118.63 M | - |
| Sept 2017 | - | $379.71 M(+17.4%) |
| June 2017 | - | $323.54 M(+91.4%) |
| Mar 2017 | - | $169.02 M(+2796.5%) |
| Dec 2016 | - | $5.84 M(-109.6%) |
| Sept 2016 | - | -$60.87 M(-52.2%) |
| June 2016 | - | -$127.30 M(-86.8%) |
| Mar 2016 | - | -$965.12 M(-4.8%) |
| Dec 2015 | - | -$1.01 B(+244.0%) |
| Sept 2015 | - | -$294.75 M(-25.2%) |
| June 2015 | - | -$394.04 M(+174.7%) |
| Mar 2015 | - | -$143.45 M(-51.8%) |
| Dec 2014 | - | -$297.50 M |
FAQ
- What is 10x Genomics annual retained earnings?
- What is the all time high annual retained earnings for 10x Genomics?
- What is 10x Genomics quarterly retained earnings?
- What is the all time high quarterly retained earnings for 10x Genomics?
- What is 10x Genomics quarterly retained earnings year-on-year change?
What is 10x Genomics annual retained earnings?
The current annual retained earnings of TXG is -$1.28 B
What is the all time high annual retained earnings for 10x Genomics?
10x Genomics all-time high annual retained earnings is -$118.63 M
What is 10x Genomics quarterly retained earnings?
The current quarterly retained earnings of TXG is -$1.42 B
What is the all time high quarterly retained earnings for 10x Genomics?
10x Genomics all-time high quarterly retained earnings is $379.71 M
What is 10x Genomics quarterly retained earnings year-on-year change?
Over the past year, TXG quarterly retained earnings has changed by -$133.60 M (-10.40%)